Business
Notice of Preliminary Results
Notice of Preliminary Results.
About this update from Arecor Therapeutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3109G\n Arecor Therapeutics PLC\n 29 March 2022\n \n \n \n \n Arecor Therapeutics plc\n \n \n (\"Arecor\" or the \"Group\")\n \n \n \n \n \n NOTICE OF PRELIMINARY RESULTS\n \n \n \n \n \n \n Cambridge, UK, \n \n 29 March 2022:\n Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, \n will announce its preliminary results for the year ended 31 December 2021 on Monday 25 April 2022.\n \n \n \n \n \n Sarah Howell, Chief Executive Officer, and Susan Lowther, Chief Financial Officer, will host an in-person briefing for analysts at 11:00am BST on the day of the results at the offices of Panmure Gordon, One New Change, London, EC4M 9AF. There will also be a live webcast and conference call with a Q&A session.\n \n \n \n \n \n For more details or to attend the briefing, please contact \n \n [email protected]\n \n \n \n \n \n \n \n \n \n -ENDS-\n \n \n \n \n \n \n \n \n For more information, please contact: \n \n \n \n \n \n Arecor Therapeutics plc\n \n \n \n \n \n www.arecor.com\n \n \n \n \n \n \n \n Dr Sarah Howell, Chief Executive Officer\n \n \n \n \n Tel: +44 (0) 1223 426060\n \n \n Email: \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Susan Lowther, Chief Financial Officer\n \n \n \n \n Tel: +44 (0) 1223 426060\n \n \n Email: \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Mo Noonan, Communications\n \n \n \n \n Tel: +44 (0) 7876 444977\n \n \n Email: \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Panmure Gordon (UK) Limited\n \n (NOMAD and Broker) \n \n \n Freddy Crossley, Emma Earl (Corporate Finance)\n \n \n Rupert Dearden (Corporate Broking)\n \n \n \n \n Tel: +44 (0) 20 7886 2500\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n \n \n \n \n \n \n \n \n \n \n Chris Gardner, David Daley, Angela Gray\n \n \n \n \n Tel: +44 (0) 20 3709 5700\n \n \n Email: \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n Notes to Editors\n \n \n \n \n \n About Arecor \n \n \n Arecor Therapeutics plc is a globally focused biopharmaceutical...